Fish oil diet associated with acute reperfusion related hemorrhage, and with reduced stroke-related sickness behaviors and motor impairment

Frontiers in Neurology

Volumn 5 FEB, Issue , 2014, Pages

  Pascoe, Michaela C ^a   Howells, David W ^b   Crewther, David P ^a   Constantinou, Nicki ^c   Carey, Leeanne M ^b   Rewell, Sarah S ^b   Turchini, Giovanni M ^d   Kaur, Gunveen ^e   Crewther, Sheila G ^f  

^a SWINBURNE UNIVERSITY OF TECHNOLOGY   (Australia)

^b FLOREY INSTITUTE OF NEUROSCIENCE AND MENTAL HEALTH   (Australia)

^c DEAKIN UNIVERSITY   (Australia)

^d DEAKIN UNIVERSITY   (Australia)

^e VICTORIA UNIVERSITY   (Australia)

^f LA TROBE UNIVERSITY   (Australia)

Author keywords

Middle cerebral artery occlusion; Mood; Polyunsaturated fatty acids; Stroke

Indexed keywords

FISH OIL; OMEGA 3 FATTY ACID; OMEGA 6 FATTY ACID;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANXIETY; ARTICLE; BRAIN HEMORRHAGE; BRAIN INFARCTION SIZE; CEREBROVASCULAR ACCIDENT; CONTROLLED STUDY; DEPRESSION; DIET SUPPLEMENTATION; HYPERACTIVITY; ILLNESS BEHAVIOR; MALE; MOTOR DYSFUNCTION; NONHUMAN; OUTCOME ASSESSMENT; RAT; REPERFUSION; RISK FACTOR;

EID: 84895510619     PISSN: None     EISSN: 16642295     Source Type: Journal    
DOI: 10.3389/fneur.2014.00014     Document Type: Article

References (101)

1. Mackay J, Mensah G. The Atlas of Heart Disease and Stroke. Geneva: World Health Organization (2004). 112 p.
2. Burvill PW, Johnson GA, Jamrozik KD, Anderson CS, Stewart-Wynne EG, Chakera TM. Anxiety disorders after stroke: results from the Perth Community Stroke Study. Br J Psychiatry (1995) 166(3):328-32. doi: 10.1192/bjp.166.3.328.
3. Astrom M. Generalized anxiety disorder in stroke patients. A 3-year longitudinal study. Stroke (1996) 27(2):270-5. doi:10.1161/01.STR.27.2.270.
4. Linden T, Blomstrand C, Skoog I. Depressive disorders after 20 months in elderly stroke patients: a case-control study. Stroke (2007) 38(6):1860-3. doi:10.1161/STROKEAHA.106.471805.
5. Kessler RC, Nelson CB, McGonagle KA, Liu J, Swartz M, Blazer DG. Comorbidity of DSM-III-R major depressive disorder in the general population: results from the US National Comorbidity Survey. Br J Psychiatry Suppl (1996) 168(30):17-30.
6. Hirschfeld RM. The comorbidity of major depression and anxiety disorders: recognition and management in primary care. Prim Care Companion J Clin Psychiatry (2001) 3(6):244-54. doi:10.4088/PCC.v03n0609.
7. Pandharipande P, Cotton BA, Shintani A, Thompson J, Pun BT, Morris JA Jr., et al. Prevalence and risk factors for development of delirium in surgical and trauma intensive care unit patients. J Trauma (2008) 65(1):34-41. doi:10.1097/TA.0b013e31814b2c4d.
8. Tully PJ, Baker RA, Winefield HR, Turnbull DA. Depression, anxiety disorders and type D personality as risk factors for delirium after cardiac surgery. Aust N Z J Psychiatry (2010) 44(11):1005-11. doi:10.3109/00048674.2010.495053.
9. McManus J, Pathansali R, Stewart R, Macdonald A, Jackson S. Delirium post-stroke. Age Ageing (2007) 36(6):613-8. doi:10.1093/ageing/afm140.
10. Masskulpan P, Riewthong K, Dajpratham P, Kuptniratsaikul V. Anxiety and depressive symptoms after stroke in 9 rehabilitation centers. J Med Assoc Thai (2008) 91(10):1595-602.
11. Dantzer R, O'Connor JC, Freund GG, Johnson RW, Kelley KW. From inflammation to sickness and depression: when the immune system subjugates the brain. Nat Rev Neurosci (2008) 9(1):46-56. doi:10.1038/nrn2297.
12. Pascoe MC, Crewther SG, Carey LM, Crewther DP. What you eat is what you are-a role for polyunsaturated fatty acids in neuroinflammation induced depression? Clin Nutr (2011) 30(4):407-15. doi:10.1016/j.clnu.2011.03.013.
13. Ross BM. Omega-3 polyunsaturated fatty acids and anxiety disorders. Prostaglandins Leukot Essent Fatty Acids (2009) 81(5-6):309-12. doi:10.1016/j.plefa.2009.10.004.
14. Lavialle M, Denis I, Guesnet P, Vancassel S. Involvement of omega-3 fatty acids in emotional responses and hyperactive symptoms. J Nutr Biochem (2010) 21(10):899-905. doi:10.1016/j.jnutbio.2009.12.005.
15. Appleton KM, Rogers PJ, Ness AR. Is there a role for n-3 long-chain polyunsaturated fatty acids in the regulation of mood and behaviour? A review of the evidence to date from epidemiological studies, clinical studies and intervention trials. Nutr Res Rev (2008) 21(1):13-41. doi:10.1017/S0954422408998620.
16. Bays HE. Safety considerations with omega-3 fatty acid therapy. Am J Cardiol (2007) 99(6A):35C-43C. doi:10.1016/j.amjcard.2006.11.020.
17. Stone NJ. Fish consumption, fish oil, lipids, and coronary heart disease. Circulation (1996) 94(9):2337-40. doi:10.1161/01.CIR.94.9.2337.
18. Park Y, Nam S, Yi HJ, Hong HJ, Lee M. Dietary n-3 polyunsaturated fatty acids increase oxidative stress in rats with intracerebral hemorrhagic stroke. Nutr Res (2009) 29(11):812-8. doi:10.1016/j.nutres.2009.10.019.
19. Belayev L, Marcheselli VL, Khoutorova L, Rodriguez de Turco EB, Busto R, Ginsberg MD, et al. Docosahexaenoic acid complexed to albumin elicits high-grade ischemic neuroprotection. Stroke (2005) 36(1):118-23. doi:10.1161/01.STR.0000149620.74770.2e.
20. Zhang W, Hu X, Yang W, Gao Y, Chen J. Omega-3 polyunsaturated fatty acid supplementation confers long-term neuroprotection against neonatal hypoxic-ischemic brain injury through anti-inflammatory actions. Stroke (2010) 41(10):2341-7. doi:10.1161/STROKEAHA.110.586081.
21. Choi-Kwon S, Park KA, Lee HJ, Park MS, Lee JH, Jeon SE, et al. Temporal changes in cerebral antioxidant enzyme activities after ischemia and reperfusion in a rat focal brain ischemia model: effect of dietary fish oil. Brain Res Dev Brain Res (2004) 152(1):11-8. doi:10.1016/j.devbrainres.2004.05.004.
22. Petullo D, Masonic K, Lincoln C, Wibberley L, Teliska M, Yao DL. Model development and behavioral assessment of focal cerebral ischemia in rats. Life Sci (1999) 64(13):1099-108. doi:10.1016/S0024-3205(99)00038-7.
23. Bederson JB, Pitts LH, Tsuji M, Nishimura MC, Davis RL, Bartkowski H. Rat middle cerebral artery occlusion: evaluation of the model and development of a neurologic examination. Stroke (1986) 17(3):472-6. doi:10.1161/01.STR.17.3.472.
24. Lolic MM, Fiskum G, Rosenthal RE. Neuroprotective effects of acetyl-L-carnitine after stroke in rats. Ann Emerg Med (1997) 29(6):758-65. doi:10.1016/S0196-0644(97)70197-5.
25. Akpan N, Serrano-Saiz E, Zacharia BE, Otten ML, Ducruet AF, Snipas SJ, et al. Intranasal delivery of caspase-9 inhibitor reduces caspase-6-dependent axon/neuron loss and improves neurological function after stroke. J Neurosci (2011) 31(24):8894-904. doi:10.1523/JNEUROSCI.0698-11.2011.
26. Garg P, Duncan RS, Kaja S, Zabaneh A, Chapman KD, Koulen P. Lauroylethanolamide and linoleoylethanolamide improve functional outcome in a rodent model for stroke. Neurosci Lett (2011) 492(3):134-8. doi:10.1016/j.neulet.2011.01.073.
27. Chandler MJ, DeLeo J, Carney JM. An unanesthetized-gerbil model of cerebral ischemia-induced behavioral changes. J Pharmacol Methods (1985) 14(2):137-46. doi:10.1016/0160-5402(85)90051-8.
28. Wang D, Corbett D. Cerebral ischemia, locomotor activity and spatial mapping. Brain Res (1990) 533(1):78-82. doi:10.1016/0006-8993(90)91798-L.
29. Kuroiwa T, Bonnekoh P, Hossmann KA. Therapeutic window of halothane anesthesia for reversal of delayed neuronal injury in gerbils: relationship to postischemic motor hyperactivity. Brain Res (1991) 563(1-2):33-8. doi:10.1016/0006-8993(91)91511-X.
30. Kuroiwa T, Bonnekoh P, Hossmann KA. Locomotor hyperactivity and hippocampal CA1 injury after transient forebrain ischemia of gerbils. Neurosci Lett (1991) 122(2):141-4. doi:10.1016/0304-3940(91)90842-H.
31. Liu P, Bilkey DK. The effect of excitotoxic lesions centered on the hippocampus or perirhinal cortex in object recognition and spatial memory tasks. Behav Neurosci (2001) 115(1):94-111. doi:10.1037/0735-7044.115.1.94.
32. Mumby DG, Gaskin S, Glenn MJ, Schramek TE, Lehmann H. Hippocampal damage and exploratory preferences in rats: memory for objects, places, and contexts. Learn Mem (2002) 9(2):49-57. doi:10.1101/lm.41302.
33. Save E, Poucet B, Foreman N, Buhot MC. Object exploration and reactions to spatial and nonspatial changes in hooded rats following damage to parietal cortex or hippocampal formation. Behav Neurosci (1992) 106(3):447-56. doi:10.1037/0735-7044.106.3.447.
34. Callaway JK, Knight MJ, Watkins DJ, Beart PM, Jarrott B. Delayed treatment with AM-36, a novel neuroprotective agent, reduces neuronal damage after endothelin-1-induced middle cerebral artery occlusion in conscious rats. Stroke (1999) 30(12):2704-12; discussion 12. doi:10.1161/01.STR.30.12.2704.
35. Miller AA, Dusting GJ, Roulston CL, Sobey CG. NADPH-oxidase activity is elevated in penumbral and non-ischemic cerebral arteries following stroke. Brain Res (2006) 1111(1):111-6. doi:10.1016/j.brainres.2006.06.082.
36. Nieuwenhuijs VB, de Bruijn MT, Schiesser M, Morphett A, Padbury RT, Barritt GJ. Ischemic preconditioning and intermittent ischemia preserve bile flow in a rat model of ischemia/reperfusion injury. Dig Dis Sci (2007) 52(11):3029-37. doi:10.1007/s10620-006-9520-7.
37. Venna VR, Deplanque D, Allet C, Belarbi K, Hamdane M, Bordet R. PUFA induce antidepressant-like effects in parallel to structural and molecular changes in the hippocampus. Psychoneuroendocrinology (2009) 34(2):199-211. doi:10.1016/j.psyneuen.2008.08.025.
38. National Health and Medical Research Council. Australian Code of Practice for the Care and Use of Animals for Scientific Purposes. 7th ed. Canberra: Australian Government (2004). 84 p.
39. Jones ML, Mark PJ, Mori TA, Keelan JA, Waddell BJ. Maternal dietary omega-3 fatty acid supplementation reduces placental oxidative stress and increases fetal and placental growth in the rat. Biol Reprod (2013) 88(2):37. doi:10.1095/biolreprod.112.103754.
40. Longa EZ, Weinstein PR, Carlson S, Cummins R. Reversible middle cerebral artery occlusion without craniectomy in rats. Stroke (1989) 20(1):84-91. doi:10.1161/01.STR.20.1.84.
41. Spratt NJ, Fernandez J, Chen M, Rewell S, Cox S, van Raay L, et al. Modification of the method of thread manufacture improves stroke induction rate and reduces mortality after thread-occlusion of the middle cerebral artery in young or aged rats. J Neurosci Methods (2006) 155(2):285-90. doi:10.1016/j.jneumeth.2006.01.020.
42. Rygula R, Abumaria N, Flugge G, Fuchs E, Ruther E, Havemann-Reinecke U. Anhedonia and motivational deficits in rats: impact of chronic social stress. Behav Brain Res (2005) 162(1):127-34. doi:10.1016/j.bbr.2005.03.009.
43. Soffie M, Buhot MC, Poucet B. Cognitive and noncognitive processes involved in selective object exploration: comparison between young adult and old rats. Physiol Behav (1992) 52(5):1029-35. doi:10.1016/0031-9384(92)90387-H.
44. Dulawa SC, Grandy DK, Low MJ, Paulus MP, Geyer MA. Dopamine D4 receptor-knock-out mice exhibit reduced exploration of novel stimuli. J Neurosci (1999) 19(21):9550-6.
45. Belzung C. Hippocampal mossy fibres: implication in novelty reactions or in anxiety behaviours? Behav Brain Res (1992) 51(2):149-55. doi:10.1016/S0166-4328(05)80208-6.
46. Montgomery KC. The relation between fear induced by novel stimulation and exploratory behavior. J Comp Physiol Psychol (1955) 48(4):254-60. doi:10.1037/h0048596.
47. Dember WN. Response by the rat to environmental change. J Comp Physiol Psychol (1956) 49(1):93-5. doi:10.1037/h0045411.
48. Andersen MB, Zimmer J, Sams-Dodd F. Postischemic hyperactivity in the Mongolian gerbil correlates with loss of hippocampal neurons. Behav Neurosci (1997) 111(6):1205-16. doi:10.1037/0735-7044.111.6.1205.
49. Kilic E, Kilic U, Bacigaluppi M, Guo Z, Abdallah NB, Wolfer DP, et al. Delayed melatonin administration promotes neuronal survival, neurogenesis and motor recovery, and attenuates hyperactivity and anxiety after mild focal cerebral ischemia in mice. J Pineal Res (2008) 45(2):142-8. doi:10.1111/j.1600-079X.2008.00568.x.
50. Monteggia LM, Luikart B, Barrot M, Theoloold D, Malkovska I, Nef S, et al. Brain-derived neurotrophic factor conditional knockouts show gender differences in depression-related behaviors. Biol Psychiatry (2007) 61(2):187-97. doi:10.1016/j.biopsych.2006.03.021.
51. van Riezen H, Leonard BE. Effects of psychotropic drugs on the behavior and neurochemistry of olfactory bulbectomized rats. In: File SE, editor. Psychopharmacology of Anxiolytics and Antidepressants. New York: Pergamon Press (1991). p. 231-50.
52. Redmond AM, Kelly JP, Leonard BE. Behavioural and neurochemical effects of dizocilpine in the olfactory bulbectomized rat model of depression. Pharmacol Biochem Behav (1997) 58(2):355-9. doi:10.1016/S0091-3057(97)00259-1.
53. Garzon J, Delrio J. Hyperactivity induced in rats by long-term isolation-further-studies on a new animal-model for the detection of anti-depressants. Eur J Pharmacol (1981) 74(4):287-94. doi:10.1016/0014-2999(81)90047-9.
54. Garzon J, Fuentes JA, Delrio J. Anti-depressants selectively antagonize the hyperactivity induced in rats by long-term isolation. Eur J Pharmacol (1979) 59(3-4):293-6. doi:10.1016/0014-2999(79)90293-0.
55. Misslin R, Cigrang M. Does neophobia necessarily imply fear or anxiety. Behav Processes (1986) 12(1):45-50. doi:10.1016/0376-6357(86)90069-0.
56. Welker WI. Free versus forced exploration of a novel situation by rats. Psychol Rep (1957) 3(1):95-108. doi:10.2466/pr0.1957.3.g.95.
57. Bevins RA, Besheer J. Object recognition in rats and mice: a one-trial non-matching-to-sample learning task to study "recognition memory". Nat Protoc (2006) 1(3):1306-11. doi:10.1038/nprot.2006.205.
58. Sinclair AJ, O'Dea K, Dunstan G, Ireland PD, Niall M. Effects on plasma lipids and fatty acid composition of very low fat diets enriched with fish or kangaroo meat. Lipids (1987) 22(7):523-9. doi:10.1007/BF02540369.
59. Ackman RG. The gas chromatograph in practical analyses of common and uncommon fatty acids for the 21st century. Anal Chim Acta (2002) 465(1-2):175-92. doi:10.1016/S0003-2670(02)00098-3.
60. Field A, Miles J. Discovering Statistics Using SAS. London: SAGE Publications Ltd (2010).
61. Paik M-J, Shin JY, Lee G, Ahn YH. Monitoring of altered free fatty acid metabolic patterns in rat plasma following hemorrhagic stroke. Anal Lett (2011) 44(7):1323-32. doi:10.1080/00032719.2010.512678.
62. Clarke J, Herzberg G, Peeling J, Buist R, Corbett D. Dietary supplementation of omega-3 polyunsaturated fatty acids worsens forelimb motor function after intracerebral hemorrhage in rats. Exp Neurol (2005) 191(1):119-27. doi:10.1016/j.expneurol.2004.09.003.
63. Huang YS, Watanabe Y, Horrobin DF, Simmons V. Fatty acid changes in liver choline and ethanolamine glycerophospholipids in aspirin-treated rats fed linoleate, gamma-linolenate and fish oil. Clin Physiol Biochem (1989) 7(2):79-86.
64. Badjatia N, Seres D, Carpenter A, Schmidt JM, Lee K, Mayer SA, et al. Free fatty acids and delayed cerebral ischemia after subarachnoid hemorrhage. Stroke (2012) 43(3):691-6. doi:10.1161/STROKEAHA.111.636035.
65. Corcoran TB, Mas E, Barden AE, Durand T, Galano JM, Roberts LJ, et al. Are isofurans and neuroprostanes increased after subarachnoid hemorrhage and traumatic brain injury? Antioxid Redox Signal (2011) 15(10):2663-7. doi:10.1089/ars.2011.4125.
66. Hsieh YP, Lin CL, Shiue AL, Yin H, Morrow JD, Hsu JC, et al. Correlation of F4-neuroprostanes levels in cerebrospinal fluid with outcome of aneurysmal subarachnoid hemorrhage in humans. Free Radic Biol Med (2009) 47(6):814-24. doi:10.1016/j.freeradbiomed.2009.06.026.
67. Pilitsis JG, Coplin WM, O'Regan MH, Wellwood JM, Diaz FG, Fairfax MR, et al. Free fatty acids in human cerebrospinal fluid following subarachnoid hemorrhage and their potential role in vasospasm: a preliminary observation. J Neurosurg (2002) 97(2):272-9. doi:10.3171/jns.2002.97.2.0272.
68. Shirao S, Fujisawa H, Kudo A, Kurokawa T, Yoneda H, Kunitsugu I, et al. Inhibitory effects of eicosapentaenoic acid on chronic cerebral vasospasm after subarachnoid hemorrhage: possible involvement of a sphingosylphosphorylcholine-rho-kinase pathway. Cerebrovasc Dis (2008) 26(1):30-7. doi:10.1159/000135650.
69. Yoneda H, Shirao S, Kurokawa T, Fujisawa H, Kato S, Suzuki M. Does eicosapentaenoic acid (EPA) inhibit cerebral vasospasm in patients after aneurysmal subarachnoid hemorrhage? Acta Neurol Scand (2008) 118(1):54-9. doi:10.1111/j.1600-0404.2007.00983.x.
70. Kromann N, Green A. Epidemiological studies in the Upernavik district, Greenland. Incidence of some chronic diseases 1950-1974. Acta Med Scand (1980) 208(5):401-6. doi:10.1111/j.0954-6820.1980.tb01221.x.
71. Bjerregaard P, Mulvad G, Pedersen HS. Regional variation in cardiovascular risk factors and ischemic heart disease mortality in Greenland. Int J Circumpolar Health (1998) 57(Suppl 1):302-5.
72. Pilitsis JG, Coplin WM, O'Regan MH, Wellwood JM, Diaz FG, Fairfax MR, et al. Measurement of free fatty acids in cerebrospinal fluid from patients with hemorrhagic and ischemic stroke. Brain Res (2003) 985(2):198-201. doi:10.1016/S0006-8993(03)03044-0.
73. Gasparovic C, Rosenberg GA, Wallace JA, Estrada EY, Roberts K, Pastuszyn A, et al. Magnetic resonance lipid signals in rat brain after experimental stroke correlate with neutral lipid accumulation. Neurosci Lett (2001) 301(2):87-90. doi:10.1016/S0304-3940(01)01616-0.
74. Nakano S, Kogure K, Abe K, Yae T. Ischemia-induced alterations in lipid metabolism of the gerbil cerebral cortex: I. Changes in free fatty acid liberation. J Neurochem (1990) 54(6):1911-6. doi:10.1111/j.1471-4159.1990.tb04890.x.
75. Narita K, Kubota M, Nakane M, Kitahara S, Nakagomi T, Tamura A, et al. Therapeutic time window in the penumbra during permanent focal ischemia in rats: changes of free fatty acids and glycerophospholipids. Neurol Res (2000) 22(4):393-400.
76. Jaillard A, Cornu C, Durieux A, Moulin T, Boutitie F, Lees KR, et al. Hemorrhagic transformation in acute ischemic stroke. The MAST-E study. MAST-E Group. Stroke (1999) 30(7):1326-32. doi:10.1161/01.STR.30.7.1326.
77. Motto C, Ciccone A, Aritzu E, Boccardi E, De Grandi C, Piana A, et al. Hemorrhage after an acute ischemic stroke. MAST-I Collaborative Group. Stroke (1999) 30(4):761-4. doi:10.1161/01.STR.30.4.761.
78. Motto C, Aritzu E, Boccardi E, De Grandi C, Piana A, Candelise L. Reliability of hemorrhagic transformation diagnosis in acute ischemic stroke. Stroke (1997) 28(2):302-6. doi:10.1161/01.STR.28.2.302.
79. Alexandrov AV, Black SE, Ehrlich LE, Caldwell CB, Norris JW. Predictors of hemorrhagic transformation occurring spontaneously and on anticoagulants in patients with acute ischemic stroke. Stroke (1997) 28(6):1198-202. doi:10.1161/01.STR.28.6.1198.
80. Berliner AR, Fine DM. There's something fishy about this bleeding. NDT Plus (2011) 4(4):270-2. doi:10.1093/ndtplus/sfr046.
81. Balk E, Chung M, Lichtenstein A, Chew P, Kupelnick B, Lawrence A, et al. Effects of omega-3 fatty acids on cardiovascular risk factors and intermediate markers of cardiovascular disease. In: Evidence Report/Technology Assessment No. 93. Rockville, MD: Agency for Healthcare Research and Quality (2004). p. 1-6.
82. Wallace JM, McCabe AJ, Roche HM, Higgins S, Robson PJ, Gilmore WS, et al. The effect of low-dose fish oil supplementation on serum growth factors in healthy humans. Eur J Clin Nutr (2000) 54(9):690-4. doi:10.1038/sj.ejcn.1601076.
83. Eritsland J, Arnesen H, Gronseth K, Fjeld NB, Abdelnoor M. Effect of dietary supplementation with n-3 fatty acids on coronary artery bypass graft patency. Am J Cardiol (1996) 77(1):31-6. doi:10.1016/S0002-9149(97)89130-8.
84. Leaf A, Jorgensen MB, Jacobs AK, Cote G, Schoenfeld DA, Scheer J, et al. Do fish oils prevent restenosis after coronary angioplasty? Circulation (1994) 90(5):2248-57. doi:10.1161/01.CIR.90.5.2248.
85. Bender NK, Kraynak MA, Chiquette E, Linn WD, Clark GM, Bussey HI. Effects of marine fish oils on the anticoagulation status of patients receiving chronic warfarin therapy. J Thromb Thrombolysis (1998) 5(3):257-61. doi:10.1023/A:1008852127668.
86. Harris WS. Expert opinion: omega-3 fatty acids and bleeding-cause for concern? Am J Cardiol (2007) 99(6A):44C-6C. doi:10.1016/j.amjcard.2006.11.021.
87. Knapp HR. Dietary fatty acids in human thrombosis and hemostasis. Am J Clin Nutr (1997) 65(5 Suppl):1687S-98S.
88. Dantzer R. Cytokine-induced sickness behaviour: a neuroimmune response to activation of innate immunity. Eur J Pharmacol (2004) 500(1-3):399-411. doi:10.1016/j.ejphar.2004.07.040.
89. Poignet H, Beaughard M, Lecoin G, Massingham R. Functional, behavioral, and histological changes induced by transient global cerebral ischemia in rats: effects of cinnarizine and flunarizine. J Cereb Blood Flow Metab (1989) 9(5):646-54. doi:10.1038/jcbfm.1989.92.
90. Butler TL, Kassed CA, Sanberg PR, Willing AE, Pennypacker KR. Neurodegeneration in the rat hippocampus and striatum after middle cerebral artery occlusion. Brain Res (2002) 929(2):252-60. doi:10.1016/S0006-8993(01)03371-6.
91. Jin K, Minami M, Lan JQ, Mao XO, Batteur S, Simon RP, et al. Neurogenesis in dentate subgranular zone and rostral subventricular zone after focal cerebral ischemia in the rat. Proc Natl Acad Sci U S A (2001) 98(8):4710-5. doi:10.1073/pnas.081011098.
92. Nakatomi H, Kuriu T, Okabe S, Yamamoto S, Hatano O, Kawahara N, et al. Regeneration of hippocampal pyramidal neurons after ischemic brain injury by recruitment of endogenous neural progenitors. Cell (2002) 110(4):429-41. doi:10.1016/S0092-8674(02)00862-0.
93. Bendel O, Bueters T, von Euler M, Ove Ogren S, Sandin J, von Euler G. Reappearance of hippocampal CA1 neurons after ischemia is associated with recovery of learning and memory. J Cereb Blood Flow Metab (2005) 25(12):1586-95. doi:10.1038/sj.jcbfm.9600153.
94. Plamondon H, Khan S. Characterization of anxiety and habituation profile following global ischemia in rats. Physiol Behav (2005) 84(4):543-52. doi:10.1016/j.physbeh.2005.02.001.
95. Zhang ZW, Deschenes M. Intracortical axonal projections of lamina VI cells of the primary somatosensory cortex in the rat: a single-cell labeling study. J Neurosci (1997) 17(16):6365-79.
96. LaBar KS, LeDoux JE. Partial disruption of fear conditioning in rats with unilateral amygdala damage: correspondence with unilateral temporal lobectomy in humans. Behav Neurosci (1996) 110(5):991-7. doi:10.1037/0735-7044.110.5.991.
97. Friedman A, Frankel M, Flaumenhaft Y, Merenlender A, Pinhasov A, Feder Y, et al. Programmed acute electrical stimulation of ventral tegmental area alleviates depressive-like behavior. Neuropsychopharmacology (2009) 34(4):1057-66. doi:10.1038/npp.2008.177.
98. Rodriguez Echandia EL, Gonzalez AS, Cabrera R, Fracchia LN. A further analysis of behavioral and endocrine effects of unpredictable chronic stress. Physiol Behav (1988) 43(6):789-95. doi:10.1016/0031-9384(88)90378-2.
99. Katsumata T, Katayama Y, Obo R, Muramatsu H, Ohtori T, Terashi A. Delayed administration of ethyl eicosapentate improves local cerebral blood flow and metabolism without affecting infarct volumes in the rat focal ischemic model. Eur J Pharmacol (1999) 372(2):167-74. doi:10.1016/S0014-2999(99)00171-5.
100. Arterburn LM, Hall EB, Oken H. Distribution, interconversion, and dose response of n-3 fatty acids in humans. Am J Clin Nutr (2006) 83(6 Suppl):1467S-76S.
101. Moriguchi T, Loewke J, Garrison M, Catalan JN, Salem N Jr. Reversal of docosahexaenoic acid deficiency in the rat brain, retina, liver, and serum. J Lipid Res (2001) 42(3):419-27.